To further evaluate the impact of TRAF4 expression on the prognosis of lung cancer patients, we retrospectively studied the survival time of these patients, and found that a higher expression level of TRAF4 was associated with shorter progression‐free survival (PFS) (Fig. 1D). The gene discussed is TRAF4; the disease is lung carcinoma.